Panayiotidis P, Tumyan G, Thieblemont C, Ptushkin VV, et al. A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenstrom's macroglobulinemia. Leuk Lymphoma 2022 Jan 19:1-12. doi: 10.1080/10428194.2021.2015765.
PMID: 35045765